Open Access
Younger Adults' Understanding of Questions for a Service User Experience Survey. Funded/commissioned by: The Health and Social Care Information Centre
Reads0
Chats0
TLDR
User experience surveys (UESs) are regarded as an important part of the overall performance framework for social care and, providing councils with information about how they might improve services locally, and are required to submit their results to government bodies so that the relative performance of the CSSRs can be judged.Abstract:
For some time now councils with social services responsibilities (CSSRs) have been required to conduct surveys of user’s experience of social services. These have taken place nationally in three-yearly cycles. In 2002/03 the survey was for older people, in 2003/04 it was for younger adults with physical and sensory impairments, and in 2004/05 it was for children. 2005/06 marked the beginning of the second wave of the cycle. The mandate for conducting surveys of user’s experiences and satisfaction with services was first given in the white paper Modern Local Government: in Touch with the People (Department for the Environment, Trade and the Regions, 1998). In 2002 the Office of National Statistics (ONS) and SPRU developed a set of questionnaires for this purpose (Qureshi and Rowlands, 2004). Subsequent national surveys have drawn on this work to identify a set of compulsory questions for each round. User experience surveys (UESs) are regarded as an important part of the overall performance framework for social care and, providing councils with information about how they might improve services locally. Local authorities are required to submit their results to government bodies so that the relative performance of the CSSRs can be judged. This report is composed of five sections. The aims and objectives of the report are outlined in the second section and the method used to gather the data is outlined in section 3. In section 4 we report on the findings from the fieldwork and draw some conclusions and recommendations for the national survey in section 5. The topic guides for the focus groups and interviews are included in the appendices along with a brief discussion of the findings from the focus groups and a copy of the final extended questionnaire.read more
Citations
More filters
Journal ArticleDOI
Cost of disorders of the brain in Europe 2010
Anders Gustavsson,Mikael Svensson,Frank Jacobi,Christer Allgulander,Jordi Alonso,Ettore Beghi,R. Dodel,Mattias Ekman,Carlo Faravelli,Laura Fratiglioni,Brenda Gannon,David P.H. Jones,Poul Jennum,Albena Jordanova,Linus Jönsson,Korinna Karampampa,Martin Knapp,Martin Knapp,Gisela Kobelt,Tobias Kurth,Roselind Lieb,Mattias Linde,Christina Ljungcrantz,Andreas Maercker,Beatrice Melin,Massimo Moscarelli,Amir Musayev,Fiona Norwood,Martin Preisig,Maura Pugliatti,Juergen Rehm,Luis Salvador-Carulla,Brigitte Schlehofer,Roland Simon,Hans-Christoph Steinhausen,Lars Jacob Stovner,Jean-Michel Vallat,Peter Van den Bergh,Jim van Os,Jim van Os,Pieter E. Vos,Weili Xu,Hans-Ulrich Wittchen,Bengt Jönsson,Jes Olesen +44 more
TL;DR: The present report presents much improved cost estimates for the total cost of disorders of the brain in Europe in 2010, covering 19 major groups of disorders, 7 more than previously, of an increased range of age groups and more cost items.
Article: Health Economics Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs
TL;DR: In this article, a top-down approach was used to estimate the current and future economic burdens of Type 1 and Type 2 diabetes in the UK from aggregated data sets and literature.
Journal ArticleDOI
Data Resource Profile: Hospital Episode Statistics Admitted Patient Care (HES APC).
Annie Herbert,Linda Wijlaars,Ania Zylbersztejn,Ania Zylbersztejn,David A Cromwell,Pia Hardelid,Pia Hardelid +6 more
TL;DR: In this article, the authors identified 264 relevant publications where the primary analysis involved the use of HES APC data, and a further 130 papers where HES data had been linked to cohorts created in other datasets.
Posted Content
Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial
Catherine Henderson,Martin Knapp,Martin Knapp,José-Luis Fernández,Jennifer Beecham,Shashivadan P. Hirani,Martin Cartwright,Lorna Rixon,Michelle Beynon,Anne Rogers,Peter Bower,Helen Doll,Ray Fitzpatrick,Adam Steventon,Martin Bardsley,Jane Hendy,Stanton Newman +16 more
TL;DR: The QALY gain by patients using telehealth in addition to usual care was similar to that by patients receiving usual care only, and total costs associated with the telehealth intervention were higher, compared with standard support and treatment.
Journal ArticleDOI
Is it time to consider a role for MRI before prostate biopsy
Hashim U. Ahmed,Alex Kirkham,Manit Arya,Rowland Illing,Alex Freeman,Clare Allen,Mark Emberton +6 more
TL;DR: The use of MRI before a biopsy can serve as a triage test in men with raised serum prostate-specific antigen levels, in order to select those for biopsy with significant cancer that requires treatment, and avoid biopsy in those with no disease or insignificant cancer.
References
More filters
Journal ArticleDOI
Cost of disorders of the brain in Europe 2010
Anders Gustavsson,Mikael Svensson,Frank Jacobi,Christer Allgulander,Jordi Alonso,Ettore Beghi,R. Dodel,Mattias Ekman,Carlo Faravelli,Laura Fratiglioni,Brenda Gannon,David P.H. Jones,Poul Jennum,Albena Jordanova,Linus Jönsson,Korinna Karampampa,Martin Knapp,Martin Knapp,Gisela Kobelt,Tobias Kurth,Roselind Lieb,Mattias Linde,Christina Ljungcrantz,Andreas Maercker,Beatrice Melin,Massimo Moscarelli,Amir Musayev,Fiona Norwood,Martin Preisig,Maura Pugliatti,Juergen Rehm,Luis Salvador-Carulla,Brigitte Schlehofer,Roland Simon,Hans-Christoph Steinhausen,Lars Jacob Stovner,Jean-Michel Vallat,Peter Van den Bergh,Jim van Os,Jim van Os,Pieter E. Vos,Weili Xu,Hans-Ulrich Wittchen,Bengt Jönsson,Jes Olesen +44 more
TL;DR: The present report presents much improved cost estimates for the total cost of disorders of the brain in Europe in 2010, covering 19 major groups of disorders, 7 more than previously, of an increased range of age groups and more cost items.
Journal ArticleDOI
Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs.
TL;DR: In this article, the authors used a top-down approach to estimate the current and future economic burdens of Type 1 and Type 2 diabetics in the UK using data from aggregated data sets and literature.
Journal ArticleDOI
Data Resource Profile: Hospital Episode Statistics Admitted Patient Care (HES APC).
Annie Herbert,Linda Wijlaars,Ania Zylbersztejn,Ania Zylbersztejn,David A Cromwell,Pia Hardelid,Pia Hardelid +6 more
TL;DR: In this article, the authors identified 264 relevant publications where the primary analysis involved the use of HES APC data, and a further 130 papers where HES data had been linked to cohorts created in other datasets.
Posted Content
Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial
Catherine Henderson,Martin Knapp,Martin Knapp,José-Luis Fernández,Jennifer Beecham,Shashivadan P. Hirani,Martin Cartwright,Lorna Rixon,Michelle Beynon,Anne Rogers,Peter Bower,Helen Doll,Ray Fitzpatrick,Adam Steventon,Martin Bardsley,Jane Hendy,Stanton Newman +16 more
TL;DR: The QALY gain by patients using telehealth in addition to usual care was similar to that by patients receiving usual care only, and total costs associated with the telehealth intervention were higher, compared with standard support and treatment.
Journal ArticleDOI
Is it time to consider a role for MRI before prostate biopsy
Hashim U. Ahmed,Alex Kirkham,Manit Arya,Rowland Illing,Alex Freeman,Clare Allen,Mark Emberton +6 more
TL;DR: The use of MRI before a biopsy can serve as a triage test in men with raised serum prostate-specific antigen levels, in order to select those for biopsy with significant cancer that requires treatment, and avoid biopsy in those with no disease or insignificant cancer.